Related Experiment Video
Updated: Mar 20, 2026
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
4E-BP2 hardwires lymphocytes for rapamycin sensitivity
1Oncology-Rinat Research and Development Group, Pfizer Worldwide Research and Development, 10646 Science Center Drive/CB4, San Diego, CA 92121, USA. robert.abraham@pfizer.com.
Abstract:
The mTORC1 [mammalian (or mechanistic) target of rapamycin complex 1] inhibitor rapamycin is a potent inhibitor of T and B lymphocyte growth and proliferation. In this issue of Science Signaling, So et al found that the isoform of 4E-BP (4E-BP2) in lymphocytes that regulates messenger RNA translation is more sensitive to the effects of rapamycin than is the 4E-BP isoform found in nonlymphoid cells. Furthermore, inhibition of 4E-BP2 blocks both the growth and proliferation of lymphocytes.
Insights
Rapamycin inhibits lymphocyte growth by targeting 4E-BP2, a protein regulating translation. This specific 4E-BP2 isoform in lymphocytes is more sensitive to rapamycin, blocking T and B cell proliferation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth and proliferation.
- Rapamycin is a known inhibitor of mTORC1 and affects lymphocyte function.
- Messenger RNA translation is a critical process for protein synthesis and cell function.
Purpose of the Study:
- To investigate the specific effects of rapamycin on lymphocyte translation regulation.
- To identify the key molecular targets of rapamycin in T and B lymphocytes.
- To understand the differential sensitivity of 4E-BP isoforms to rapamycin in lymphoid versus nonlymphoid cells.
Main Methods:
- Analysis of 4E-binding protein (4E-BP) isoform sensitivity to rapamycin.
- Assessment of messenger RNA translation regulation in lymphocytes.
- Evaluation of lymphocyte growth and proliferation inhibition by rapamycin.
Main Results:
- The 4E-BP2 isoform, found in lymphocytes, is more sensitive to rapamycin than 4E-BP isoforms in nonlymphoid cells.
- Inhibition of 4E-BP2 by rapamycin effectively blocks T and B lymphocyte growth.
- Rapamycin's potent inhibition of lymphocyte proliferation is mediated through its effects on 4E-BP2.
Conclusions:
- 4E-BP2 is a critical mediator of rapamycin's inhibitory effects on lymphocyte proliferation.
- Targeting 4E-BP2 represents a key mechanism by which rapamycin controls T and B cell growth.
- These findings highlight the specific role of 4E-BP2 in lymphocyte biology and rapamycin's action.
